Peregrine Pharmaceuticals Inc is a biopharmaceutical company focused on the research, development and commercialization of novel therapeutics for cancer and a range of viral diseases. Peregrine technologies target various physical structures common to tumors or infected cells as a means to selectively target therapy and diagnostics, while sparing normal, healthy cells. Peregrine Pharmaceuticals also has a wholly-owned manufacturing subsidiary Avid Bioservices. The company was founded in 1981 as the Techniclone Corporation and changed its name to Peregrine Pharmaceuticals in 2000.
Changed name to Avid Bioservices, Inc. from Peregrine Pharmaceuticals, Inc., 1/5/2018.
CSRHub includes data on return on investment, Board, Sustainability, Task Force for Climate Related Financial Disclosure, Philanthropy, and Environment.